ECONOMIC BURDEN OF MILD AND MODERATE ASTHMA IN ADULT PATIENTS FROM PUBLIC HEALTH INSTITUTIONS PERSPECTIVE IN MEXICO

被引：0
|
作者：
Paz, Palomo E. J. [1 ]
Hernandez-Tapia, F. Z. [1 ]
Pacheco, Martinez, V [1 ]
Peralta-Hernandez, L. J. [1 ]
Juarez, Escobar Y. [1 ]
Gasga, Frias A. E. [1 ]
Molina, Soto H. [2 ]
Buritica, M. P. [3 ]
Hernandez, R. [3 ]
Moncayo-Coello, V [4 ]
Lopez-Estrada, E. [5 ]
机构：
[1] HS Estudios Farmacoecon SA CV, Mexico City, DF, Mexico
[2] Agencia Mexicana Evaluac Tecnol Sanitarias AC, Iztapalapa, Mexico
[3] AstraZeneca, Mexico City, DF, Mexico
[4] Hosp Juarez Mexico, Mexico City, DF, Mexico
[5] Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE454
引用
收藏
页码：S140 / S140
页数：1
相关论文
共 50 条
  • [21] Economic burden of severe asthma in Turkey: a cost of illness study from payer perspective
    Bavbek, S.
    Malhan, S.
    Mungan, D.
    Misirligil, Z.
    Erdinc, M.
    Gemicioglu, B.
    Oguzulgen, I. Kivilcim
    Oksuz, E.
    Yildiz, F.
    Yorgancioglu, A.
    EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 53 (03) : 128 - 137
  • [22] Moderate to Severe Osteoarthritis: What is the Economic Burden for Patients and the Health Care System? Insights from the "PONOS" Study
    Savvari, P.
    Skiadas, I.
    Barmpouni, M.
    Papadakis, S. A.
    Psychogios, V.
    Pastroudis, A. P.
    Skarpas, G. A.
    Tsoutsanis, A.
    Garofalakis, A.
    Katsifis, G.
    Argyropoulou, O. D.
    Boumpas, D.
    Menegas, D.
    CARTILAGE, 2024, 15 (03) : 268 - 277
  • [23] The economic burden of mild-to-moderate atopic dermatitis in the United States: analyses of the National Health and Wellness Survey
    Silverberg, J. I.
    Gruben, D.
    Smith, T. W.
    Fung, S.
    Myers, D. E.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (04) : E101 - E101
  • [24] ECONOMIC EVALUATION AND BUDGET IMPACT ANALYSIS OF PROTHROMBIN COMPLEX CONCENTRATE (BERIPLEX®) FOR TREATMENT AND PROPHYLAXIS OF BLEEDING IN PATIENTS TREATED WITH ORAL ANTICOAGULANTS UNDER PERSPECTIVE OF HEALTH PUBLIC INSTITUTIONS IN MEXICO
    Maciel-Hernandez, H.
    Paladio-Hemandez, J.
    Salazar-Alvarado, B.
    VALUE IN HEALTH, 2017, 20 (09) : A550 - A550
  • [25] FORCED VITAL CAPACITY RESPONSE TO TIOTROPIUM RESPIMAT® IN ADULT PATIENTS WITH SEVERE, MODERATE AND MILD SYMPTOMATIC ASTHMA
    Frith, Peter
    Halpin, David
    Moroni-Zentgraf, Petra
    Van Hecke, Benjamin
    Sigmund, Ralf
    Kerstjens, Huib
    RESPIROLOGY, 2017, 22 : 10 - 11
  • [26] Epidemiology and economic burden of Huntington's disease: a Canadian provincial public health system perspective
    Shaw, Eileen
    Mayer, Michelle
    Ekwaru, Paul
    McMullen, Suzanne
    Graves, Erin
    Wu, Jennifer W.
    Budd, Nathalie
    Maturi, Bridget
    Cowling, Tara
    Mestre, Tiago A.
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 212 - 219
  • [27] Adding formoterol to budesonide in moderate asthma -: health economic results from the FACET study
    Andersson, F
    Ståhl, E
    Barnes, PJ
    Löfdahl, CG
    O'Byrne, PM
    Pauwels, RA
    Postma, DS
    Tattersfield, AE
    Ullman, A
    RESPIRATORY MEDICINE, 2001, 95 (06) : 505 - 512
  • [28] Hospital readmission and economic burden of venous thromboembolism: From a health plan perspective
    Spyropoulos, Alex
    Lin, Jay
    CHEST, 2006, 130 (04) : 260S - 260S
  • [29] Economic evaluation of second-line therapies in adult patients with asthma when considering compliance-an analysis from a swedish health care perspective
    Pettersson, B.
    Soroncz-Szabo, T.
    Ekman, M.
    Taylor, S. D.
    VALUE IN HEALTH, 2007, 10 (06) : A401 - A401
  • [30] An Older Adult Falls Research Agenda from a Public Health Perspective
    Stevens, Judy A.
    Baldwin, Grant T.
    Ballesteros, Michael F.
    Noonan, Rita K.
    Sleet, David A.
    CLINICS IN GERIATRIC MEDICINE, 2010, 26 (04) : 767 - +
12345